Modification of BRCA1-Associated Breast Cancer Risk by the Polymorphic Androgen-Receptor CAG Repeat

This publication has 24 references indexed in Scilit:

• The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi Jews
  New England Journal of Medicine, 1997
• Association of Prostate Cancer Risk With Genetic Polymorphisms in Vitamin D Receptor and Androgen Receptor
  JNCI Journal of the National Cancer Institute, 1997
• BRCA1 expression is not directly responsive to estrogen
  Oncogene, 1997
• Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids
  The Journal of Steroid Biochemistry and Molecular Biology, 1996
• Risk modifiers in carriers of brca1 mutations
  International Journal of Cancer, 1995
• Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation
  Nature Genetics, 1995
• Androgens induce divergent proliferative responses in human breast cancer cell lines
  The Journal of Steroid Biochemistry and Molecular Biology, 1995
• Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)_n-expanded neuronopathies
  Human Molecular Genetics, 1995
• Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
  Nature, 1991
• The Robust Inference for the Cox Proportional Hazards Model
  Journal of the American Statistical Association, 1989